Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TScan Therapeutics (TCRX) Treasury Shares (2020 - 2021)

TScan Therapeutics (TCRX) has disclosed Treasury Shares for 2 consecutive years, with $116870.0 as the latest value for Q4 2021.

  • On a quarterly basis, Treasury Shares fell 73.33% to $116870.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $116870.0, a 73.33% decrease, with the full-year FY2021 number at $116870.0, down 73.33% from a year prior.
  • Treasury Shares was $116870.0 for Q4 2021 at TScan Therapeutics, down from $204513.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $438280.0 in Q4 2020 to a low of $116870.0 in Q4 2021.